Investing.com - Fresenius Medical Care ADR reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Fresenius Medical Care ADR announced earnings per share of $0.41 on revenue of $5.3B. Analysts polled by Investing.com anticipated EPS of $0.39 on revenue of $5.01B.
Fresenius Medical Care ADR shares are down 53.05% from the beginning of the year and are trading at $15.24 , down-from-52-week-high.
Fresenius Medical Care ADR follows other major Healthcare sector earnings this month
Fresenius Medical Care ADR's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, compared to forecasts EPS of $1.91 on revenue of $6.91B.
Pfizer had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.78 on revenue of $22.6B, compared to forecast for EPS of $1.44 on revenue of $21.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar